Clisma lax - occasional constipation treatment 4 enemas 133 ml

Product Description

Disposable evacuative enema useful in case of occasional constipation.

Indications

Lax enema is used in the short-term treatment of occasional constipation.

Composition

Active ingredients

100 ml contain 13.91 g of anhydrous monobasic sodium phosphate (NaH 2 PO 4 ); 3.18 g of dibasic sodium phosphate (Na 2 HPO 4 ).

Excipients

Sodium hydroxide, sodium benzoate, methyl parahydroxybenzoate, purified water.

Directions for use and Dosage

Adults and adolescents (12-18 years): the entire dose of the bottle.

Method of administration: Do not exceed the recommended doses. Laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Preferably take in the evening.

Warnings

Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause serious side effects. Laxatives can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium), and other essential nutrients. In more severe cases, dehydration or hypokalemia may occur, which can lead to cardiac or neuromuscular dysfunction, especially in the case of concomitant treatment with cardiac glycosides, diuretics, or corticosteroids.

Abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, the possible need to gradually increase the dosage), chronic constipation, and loss of normal intestinal functions (intestinal atony). Treatment of chronic or recurrent constipation always requires medical intervention for diagnosis, prescription of medications, and monitoring during therapy.

Consult your doctor when the need for a laxative arises from a sudden change in previous bowel habits (frequency and characteristics of bowel movements) that lasts for more than a few days. For two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly or unhealthy subjects to consult their doctor before using the medicine. Do not use laxatives if abdominal pain, nausea, and vomiting are present.

Prolonged use can lead to dehydration. The product should therefore be used only in occasional administrations. Paediatric population In children under 12 years of age, the medicine may be contraindicated. should be used only after consulting your doctor.

Contraindications

• Hypersensitivity to the active substances or to any of the excipients
• Acute abdominal pain or pain of unknown origin
• Nausea or vomiting
• Intestinal obstruction or stenosis or anorectal stenosis
• Intestinal sub-occlusion
• Mechanical ileus
• Paralytic ileus
• Intestinal disorders of an inflammatory nature and other conditions that may increase the absorption of the medicinal product
• Anal perforation
• Congenital or acquired megacolon
• Hirschsprung's disease
• Rectal bleeding of unknown origin
• Acute haemorrhoidal crisis with pain and bleeding
• Severe state of dehydration
• Children under twelve years of age.
• Phosphates are contraindicated in patients with cardiac disorders, severe renal insufficiency or in the presence of hyperphosphatemia. Other preparations containing sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously.

Undesirable effects

Occasionally: isolated cramping pain or abdominal colic, more frequent in cases of severe constipation. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important, as it allows continued monitoring of the benefit/risk balance of the medicinal product.

Overdose

Excessive doses may cause abdominal pain and diarrhoea; the resulting loss of fluids and electrolytes must be replaced.

Pregnancy and breastfeeding

If you are pregnant, think you may be pregnant or are planning to become pregnant, or if you are breastfeeding, ask your doctor for advice before taking Clismalax 4 enemas 133 ml.

There are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore, the medicine should be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk to the fetus or infant.

Format

4 enemas of 133 ml